Naproxen Orion (Naproxen)

Naproxen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for the production of prostaglandins. Lower prostaglandin levels diminish the signals that cause pain, swelling, and fever, resulting in analgesic, anti‑inflammatory, and antipyretic effects.

The specific dose and dosing schedule for Naproxen Orion are determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of naproxen during pregnancy and lactation depends on the trimester and clinical circumstances. Generally, NSAIDs are avoided in the third trimester because of fetal risks, and caution is advised during the first two trimesters. Breastfeeding mothers should consult their healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details, and any necessary import documentation.

Naproxen has a relatively long half‑life compared with ibuprofen, allowing twice‑daily dosing for many patients. Its analgesic and anti‑inflammatory potency is comparable to other non‑selective NSAIDs, but individual tolerability, especially gastrointestinal risk, may differ. Clinicians choose based on patient history and required dosing frequency.

Naproxen Orion should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, excessive heat, and direct sunlight to maintain stability and potency throughout its shelf life.

Naproxen Orion is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. Patients should swallow the tablet whole and not crush or chew it unless directed by a healthcare professional.

The most serious risks include gastrointestinal bleeding or ulceration, severe renal impairment, hepatic injury, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored for signs of bleeding, changes in kidney or liver function, and any unusual skin eruptions.

Naproxen Orion should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or those taking anticoagulants without close medical supervision. It is also contraindicated in the third trimester of pregnancy.